Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population

It remains unclear how different uses of angiotensin-converting inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) influence the progression of chronic kidney disease (CKD). This study explored CKD progression in a multicentre, longitudinal cohort study that included 2639 patients with CKD s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Cai-Mei, Wang, Jia-Yi, Chen, Tzu-Ting, Wu, Yun-Chun, Wu, Yi-Lien, Lin, Hsin-Ting, Chiu, Sheng-Po, Chang, Tian-Jong, Zheng, Jing-Quan, Chu, Nain-Feng, Lin, Yu-Me, Su, Sui-Lung, Lu, Kuo-Cheng, Chen, Jin-Shuen, Sung, Fung-Chang, Lee, Chien-Te, Yang, Yu, Hwang, Shang-Jyh, Wang, Ming-Cheng, Hsu, Yung-Ho, Chiou, Hung-Yi, Kao, Senyeong, Wu, Mei-Yi, Lin, Yuh-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389886/
https://www.ncbi.nlm.nih.gov/pubmed/30804406
http://dx.doi.org/10.1038/s41598-019-38991-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389886/
https://www.ncbi.nlm.nih.gov/pubmed/30804406
http://dx.doi.org/10.1038/s41598-019-38991-z

Ejemplares similares